Search results
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe randomised, global, double-blind, vehicle-controlled, dose-ranging trial is designed to assess...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 3 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 4 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Ultravate side effects: What they are and how to manage them
Healthline· 4 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that ...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 3 days agoTremfya is an interleukin (IL)-23 and CD64-inhibiting monoclonal antibody. It was first approved as...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 1 day agoIn these studies, bimekizumab consistently demonstrated sustained improvements...